Trends in the Mortality Rate of Major Kidney Diseases - China, 2014-2021.

China CDC Wkly

National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Published: November 2024

Introduction: Kidney disease represents a significant public health issue in China, yet there is a lack of comprehensive knowledge regarding national and regional trends in its mortality and causes. This study evaluated the mortality, causes, and regional distribution of major kidney diseases in China from 2014 to 2021.

Methods: Data pertaining to kidney disease were obtained from the National Death Cause Surveillance System. Estimates were made for both the mortality rates and age-standardized mortality rates (ASMR) for kidney cancer, glomerular disease, tubulointerstitial nephritis, and kidney failure. Additionally, the average annual percent change (AAPC) was calculated to illustrate trends by sex, urban/rural distinctions, and regional differences from 2014 to 2021.

Results: There was a significant reduction in the ASMR for all kidney diseases combined from 2014 to 2021. Analysis of age-specific mortality rates reveals a gradual increase beginning at age 35, with a sharp rise after age 60. However, the ASMR for glomerular disease and kidney failure in females, as well as for tubulointerstitial nephritis in males, displayed a notable decrease. Regionally, the ASMR for glomerular disease in the eastern region and kidney failure in the western region significantly decreased by AAPC of -4.6% and -2.3%, respectively. Conversely, the ASMR for kidney cancer in the central region rose significantly (AAPC=2.1%).

Conclusion: From 2014 to 2021, the ASMR for major kidney diseases remained high among men, urban residents, and individuals in western China. Future prevention and control initiatives should prioritize these disparities to mitigate the impact of kidney diseases.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11561366PMC
http://dx.doi.org/10.46234/ccdcw2024.236DOI Listing

Publication Analysis

Top Keywords

kidney diseases
20
kidney
12
major kidney
12
mortality rates
12
asmr kidney
12
glomerular disease
12
kidney failure
12
trends mortality
8
diseases china
8
kidney disease
8

Similar Publications

Background: Urine neutrophil gelatinase-associated lipocalin (uNGAL) is a biomarker for the early diagnosis of AKI.

Objectives: To evaluate uNGAL in dogs with non-associative immune mediated hemolytic anemia (IMHA) and to evaluate whether uNGAL correlates with disease severity markers, negative prognostic indicators and outcome.

Animals: Twenty-two dogs with non-associative IMHA and 14 healthy dogs.

View Article and Find Full Text PDF

Preserved ratio impaired spirometry, airflow obstruction, and their trajectories in relationship to chronic kidney disease: a prospective cohort study.

Sci Rep

January 2025

Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, No.2, Xihuan South Road, Beijing Economic and Technological Development Zone, Daxing District, Beijing, China.

Spirometry findings, such as restrictive spirometry and airflow obstruction, are associated with renal outcomes. Effects of spirometry findings such as preserved ratio impaired spirometry (PRISm) and its trajectories on renal outcomes are unclear. This study aimed to investigate the impact of baseline and trajectories of spirometry findings on future chronic kidney disease (CKD) events.

View Article and Find Full Text PDF

Stem cells prevent long-term deterioration of renal function after renal artery revascularization in a renovascular hypertension model in rats.

Sci Rep

January 2025

Renal Division, Department of Medicine, Universidade Federal de São Paulo, Rua Pedro de Toledo, 781, São Paulo, SP, 04039-032, Brazil.

Partial stenosis of the renal artery causes renovascular hypertension (RVH) and is accompanied by chronic renal ischemia, resulting in irreversible kidney damage. Revascularization constitutes the most efficient therapy for normalizing blood pressure (BP) and has significant benefits for renal function; however, the tissue damage caused by chronic hypoxia is not fully reversed. Mesenchymal stem cells (MSCs) have produced discrete results in minimizing RVH and renal tissue and functional improvements since the obstruction persists.

View Article and Find Full Text PDF

Renal fibrosis is widely recognized as the ultimate outcome of many chronic kidney diseases. The process of epithelial-mesenchymal transition (EMT) plays a critical role in the progression of fibrosis following renal injury. UHRF1, as a critical epigenetic regulator, may play an essential role in the pathogenesis and progression of renal fibrosis and EMT.

View Article and Find Full Text PDF

High-density lipoprotein nanoparticles spontaneously target to damaged renal tubules and alleviate renal fibrosis by remodeling the fibrotic niches.

Nat Commun

January 2025

College of Polymer Science and Engineering, West China School of Public Health, Med-X center of materials, Sichuan University, Chengdu, Sichuan, 610065, China.

Chronic kidney disease (CKD) ultimately causes renal fibrosis and end-stage renal disease, thus seriously threatens human health. However, current medications for CKD and fibrosis are inefficient, which is often due to poor targeting capability to renal tubule. In this study, we discover that biomimetic high-density lipoprotein (bHDL) lipid nanoparticles possess excellent targeting ability to injured tubular epithelial cells by kidney injury molecule-1(KIM-1) mediated internalization.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!